Table 1.
Sample ID | Sample type | Year detected | Detection location | Patient gender | Patient sexual orientation | Genome coverage (%) | Lineage | Sub-lineage | arp type | tpr type | tp0548 type | Macrolide sensitivity |
---|---|---|---|---|---|---|---|---|---|---|---|---|
14B001UK | Swab | 2014 | Tokyo | NA | NA | 93.7 | Nichols | – | 14 | d | c | S |
15A011MM | Swab | 2015 | Tokyo | Male | MSM | 98.4 | SS14 | 1B | 14 | e | f | S |
15A019HM | Swab | 2015 | Tokyo | Male | HM | 98.4 | SS14 | 8 | 14 | d | f | R |
16A013MM | Swab | 2016 | Tokyo | Male | MSM | 91.1 | SS14 | 1B | 14 | d | f | R |
17A003MM | Swab | 2017 | Tokyo | Male | MSM | 98.3 | Nichols | – | 14 | b | c | S |
17A014MM | Swab | 2017 | Tokyo | Male | MSM | 97.3 | SS14 | 1B | 14 | d | f | S |
17A017MM | Swab | 2017 | Tokyo | Male | MSM | 98.3 | SS14 | 1B | 14 | d | f | R |
17A021MM | Swab | 2017 | Tokyo | Male | MSM | 98.3 | Nichols | – | 12 | a | c | R |
17C005HM | Swab | 2017 | Tokyo | Male | HM | 90.8 | SS14 | 1B | 14 | d | f | R |
17C009HM | Swab | 2017 | Tokyo | Male | HM | 96.0 | SS14 | 1B | 14 | d | f | R |
17D002HM | Swab | 2017 | Osaka | Male | HM | 98.3 | SS14 | 1B | 14 | d | f | R |
17D006HM | Swab | 2017 | Osaka | Male | HM | 92.7 | SS14 | 1B | 14 | d | f | R |
17D009HM | Swab | 2017 | Osaka | Male | HM | 96.0 | SS14 | 1B | 14 | d | f | R |
17E002HF | Swab | 2017 | Tokyo | Female | HF | 95.2 | SS14 | 1B | 14 | d | f | R |
18C004HM | Swab | 2018 | Tokyo | Male | HM | 94.5 | SS14 | 1B | 14 | d | f | R |
18D001HM | Swab | 2018 | Osaka | Male | HM | 95.2 | SS14 | 1B | 14 | d | f | R |
18D002HM | Swab | 2018 | Osaka | Male | HM | 96.6 | SS14 | 1B | 14 | d | f | R |
18E001HF | Swab | 2018 | Tokyo | Female | HF | 97.8 | SS14 | 1B | 14 | d | f | R |
18E002HF | Swab | 2018 | Tokyo | Female | HF | 98.3 | SS14 | 1B | 14 | d | f | R |
18E016HF | Swab | 2018 | Tokyo | Female | HF | 98.2 | SS14 | 1B | 14 | d | f | R |
NA, data not available; MSM, men who have sex with men; HF, heterosexual female; HM, heterosexual male; S, sensitive; R, resistant.